Deferasirox for managing iron overload in people with thalassaemia

BACKGROUND: Thalassaemia is a hereditary anaemia due to ineffective erythropoiesis. In particular, people with thalassaemia major develop secondary iron overload resulting from regular red blood cell transfusions. Iron chelation therapy is needed to prevent long‐term complications. Both deferoxamine...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Bollig, Claudia, Schell, Lisa K, Rücker, Gerta, Allert, Roman, Motschall, Edith, Niemeyer, Charlotte M, Bassler, Dirk, Meerpohl, Joerg J
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2017
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6483623/
https://ncbi.nlm.nih.gov/pubmed/28809446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007476.pub3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados